Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Knatterud

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Israel Journal of Medical Sciences|May 1, 1983
Mortality experience in the diabetic retinopathy studyG L Knatterud
Controlled Clinical Trials|December 1, 1989
Thrombolysis in myocardial infarction (TIMI) randomized studies versus TIMI open label studiesG L Knatterud
Controlled Clinical Trials|May 1, 1981
Methods of quality control and of continuous audit procedures for controlled clinical trialsG L Knatterud
The New England Journal of Medicine|October 28, 1976
Diabetic retinopathy: report on photocoagulationG L Knatterud
Controlled Clinical Trials|June 1, 1995
A tribute to Christian Robert Klimt (1918-1994)G L Knatterud, C Meinart
Controlled Clinical Trials|December 1, 1987
Patient recruitment experience in the Thrombolysis in Myocardial Infarction TrialG L Knatterud, S A Forman
Blood|January 1, 1983
The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitorsM W Hilgartner, G L Knatterud
Controlled Clinical Trials|December 1, 1983
Impact of the Coronary Drug Project findings on clinical practiceL Friedman, N K Wenger, G L Knatterud
JAMA|June 29, 2000
Early risks of hormone therapy in patients with coronary heart diseaseN K Wenger, G L Knatterud, P L Canner
JAMA|November 1, 1971
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP resultsM G Goldner, G L Knatterud, T E Prout
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Israel Journal of Medical Sciences|May 1, 1983
Mortality experience in the diabetic retinopathy studyG L Knatterud
Controlled Clinical Trials|December 1, 1989
Thrombolysis in myocardial infarction (TIMI) randomized studies versus TIMI open label studiesG L Knatterud
Controlled Clinical Trials|May 1, 1981
Methods of quality control and of continuous audit procedures for controlled clinical trialsG L Knatterud
The New England Journal of Medicine|October 28, 1976
Diabetic retinopathy: report on photocoagulationG L Knatterud
Controlled Clinical Trials|June 1, 1995
A tribute to Christian Robert Klimt (1918-1994)G L Knatterud, C Meinart
Controlled Clinical Trials|December 1, 1987
Patient recruitment experience in the Thrombolysis in Myocardial Infarction TrialG L Knatterud, S A Forman
Blood|January 1, 1983
The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitorsM W Hilgartner, G L Knatterud
Controlled Clinical Trials|December 1, 1983
Impact of the Coronary Drug Project findings on clinical practiceL Friedman, N K Wenger, G L Knatterud
JAMA|June 29, 2000
Early risks of hormone therapy in patients with coronary heart diseaseN K Wenger, G L Knatterud, P L Canner
JAMA|November 1, 1971
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP resultsM G Goldner, G L Knatterud, T E Prout
Pageof 8